drugset / Trial / NCT00537979

Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis

NCT00537979

Phase 4 Completed 147 enrolled Abbott
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Prospective, non-randomized, multi-center study to assess the efficacy and safety of paricalcitol injection or oral administered over 6 months to patients with secondary hyperparathyroidism on dialysis.

Timeline

Start
2007-09
Primary completion
2010-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Paricalcitol Other / unclassified Intravenous